Genprex, Inc. Insider Trading
GNPX
Insiders sold $22 and bought nothing on the open market.
None of the selling was scheduled in advance under a 10b5-1 plan. The last open-market buy by an executive or director was in Apr 2023.
Get an email when GNPX's executives or directors buy, or make a large sale outside a plan.
Trades · last 2 years
| Date | Insider | Trade | Shares | Price | Value | Of their stake | Filing |
|---|---|---|---|---|---|---|---|
| Apr 14 | Brent M Longnecker Director | SoldNo plan 2 parts | 18 | $1.23 average | $22 | 0.2% | Form 4 |
- Apr 14No planBrent M LongneckerDirector · sold 18 at avg $1.23$220.2% of stake
Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.
Peers
Pharmaceutical Preparations · Pick stocks to compare with GNPX
Spot a number that looks wrong? Check it in GNPX's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing GNPX
A free account gives you 10 stocks a day, a watchlist and price alerts.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.